6Lieberman JR, Hsu WK. Prevention of venous thromboembolic dis- ease after total hip and knee arthroplasty [ J ]. J Bone Joint Surg Am, 2005 ; 87 : 2097 - 2112. 被引量：1
7Kanaan AO, Silva MA, Donovan JL, et al. Meta - analysis of venous thromboembolism prophylaxis in medically ill patients [J]. Clin T- her, 2007; 29:2395 -2405. 被引量：1
8Eikelboom JW, Quinlan DJ, Douketis JD. Extended- duration proph- ylaxis against venous thromboembolism after total hip or knee replace- ment : a meta - analysis of the randomized trials [ J ]. Lancet, 2001 ; 358:9 - 15. 被引量：1
9Perzborn E, Kubitza D, Misselwitz F. Rivaroxaban. A novel, oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of thromboembolic disorders [ J ]. Hamostaseologie, 2007 ; 27 : 282 - 289. 被引量：1
10Kakkar AK, Brenner B, Dalai OE, et al. Extended duration rivaroxa- ban versus short - term enoxaparin for the prevention of venous throm- boembolism after total hip arthroplasty : a double - blind, randomized controlled trial[ J]. Lancet, 2008 ; 372 : 31 - 39. 被引量：1
